NRS 689A.04047
Coverage for early refills of topical ophthalmic products.

1.

An insurer who offers or issues a policy of health insurance which provides coverage for prescription drugs shall not deny coverage for a topical ophthalmic product which is otherwise approved for coverage by the insurer when the insured, pursuant to NRS 639.2395, receives a refill of the product:

(a)

After 21 days or more but before 30 days after receiving any 30-day supply of the product;

(b)

After 42 days or more but before 60 days after receiving any 60-day supply of the product; or

(c)

After 63 days or more but before 90 days after receiving any 90-day supply of the product.

2.

The provisions of this section do not affect any deductibles, copayments or coinsurance authorized or required pursuant to the policy of health insurance.

3.

A policy of health insurance subject to the provisions of this chapter which provides coverage for prescription drugs and that is delivered, issued for delivery or renewed on or after January 1, 2016, has the legal effect of including the coverage required by this section, and any provision of the policy or renewal which is in conflict with this section is void.

4.

As used in this section, “topical ophthalmic product” means a liquid prescription drug which is applied directly to the eye from a bottle or by means of a dropper.

Source: Section 689A.04047 — Coverage for early refills of topical ophthalmic products., https://www.­leg.­state.­nv.­us/NRS/NRS-689A.­html#NRS689ASec04047.

689A.040
Contents of policy 689A.041
Coverage relating to mastectomy. 689A.042
Coverage relating to complications of pregnancy. 689A.043
Coverage of newly born and adopted children and children placed for adoption. 689A.044
Required coverage for certain tests and vaccines relating to human papillomavirus 689A.046
Benefits for treatment of alcohol or substance use disorder. 689A.0403
Procedure for arbitration of disputes concerning independent medical, dental or chiropractic evaluations. 689A.0404
Coverage for use of certain drugs for treatment of cancer. 689A.0405
Coverage for mammograms for certain women 689A.0413
Coverage for certain gynecological or obstetrical services without authorization or referral from primary care physician. 689A.0415
Coverage for hormone replacement therapy in certain circumstances 689A.0417
Coverage for health care services related to hormone replacement therapy in certain circumstances 689A.0418
Coverage for drug or device for contraception and related health services 689A.0419
Coverage for certain services, screenings and tests relating to wellness 689A.0423
Coverage for treatment of certain inherited metabolic diseases. 689A.0424
Policy that includes coverage for maternity care must not deny coverage for gestational carrier 689A.0425
Individual health benefit plan that includes coverage for maternity care and pediatric care: Requirement to allow minimum stay in hospital in connection with childbirth 689A.0427
Coverage for management and treatment of diabetes. 689A.0428
Coverage for management and treatment of sickle cell disease. 689A.0435
Coverage for autism spectrum disorders. 689A.0445
Coverage for prostate cancer screening. 689A.0447
Coverage for orally administered chemotherapy. 689A.0455
Coverage for treatment of conditions relating to severe mental illness. 689A.0463
Coverage for services provided through telehealth 689A.0465
Coverage of treatment of temporomandibular joint. 689A.04033
Coverage for treatment received as part of clinical trial or study. 689A.04036
Coverage for continued medical treatment. 689A.04042
Coverage for screening for colorectal cancer. 689A.04045
Coverage for prescription drug previously approved for medical condition of insured. 689A.04046
Coverage for prescription drugs irregularly dispensed for purpose of synchronization of chronic medications. 689A.04047
Coverage for early refills of topical ophthalmic products.
Last Updated

Jun. 24, 2021

§ 689A.04047’s source at nv​.us